Abstract

Glucocorticoid receptors (GR) in cultured fibroblasts obtained by forearm skin biopsy were characterized and GR in patients with hyper- and hypo-cortisolism were compared. Scatchard analysis of specific whole cell [3H]-dexamethasone binding showed a single class of high affinity receptors with a mean (+/- SD) binding capacity (R0) of 126,800 +/- 21,600 sites/cell and mean (+/- SD) apparent dissociation constant (Kd) of 2.9 +/- 0.4 nM in 6 normal subjects. Competition study of various steroids revealed that glucocorticoids were the most potent competitors. The order of the strength of competition was dexamethasone greater than betamethasone greater than prednisolone greater than hydrocortisone. Sucrose density gradient analysis revealed a specific 8.6 S binding peak in cytosol and 3.6 S in nuclear extracts. Dexamethasone showed the dose-dependent suppressive effect on thymidine incorporation. An inverse linear correlation between CI50 and % inhibition of thymidine incorporation by glucocorticoids was observed. There were no significant differences in parameters of whole cell GR among healthy controls, Cushing's disease (n = 4, R0 = 131,225 +/- 29,950/cell, Kd = 3.1 +/- 0.6 nM) and Addison's disease (n = 2, R0 = 131,600 +/- 25,600/cell, Kd = 3.2 +/- 0.2 nM). In one additional patient of hypercortisolism without clinical symptoms of Cushing's disease, R0 (144,000 +/- 12,960) was the same as control, but Kd (5.0 +/- 1.2 nM) was higher than the control.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.